Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB
Thomas S. Wingo, David J. Cutler, Aliza P. Wingo, et al.
JAMA Neurology (2019) Vol. 76, Iss. 7, pp. 809-809
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Daniel W. Sirkis, Luke W. Bonham, Taylor P. Johnson, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2674-2688
Open Access | Times Cited: 89
ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.
Woojin Jeong, Hyein Lee, Sukhee Cho, et al.
PubMed (2019) Vol. 42, Iss. 11, pp. 739-746
Closed Access | Times Cited: 89
Emerging risk of environmental factors: insight mechanisms of Alzheimer’s diseases
Md. Ataur Rahman, Md Saidur Rahman, Md Jamal Uddin, et al.
Environmental Science and Pollution Research (2020) Vol. 27, Iss. 36, pp. 44659-44672
Closed Access | Times Cited: 89
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
Emma M. O’Connell, Falk W. Lohoff
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 74
Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review
Mehak Agarwal, Safeera Khan
Cureus (2020)
Open Access | Times Cited: 73
Alzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies
Jéssica Diniz Pereira, Vanêssa Gomes Fraga, Anna Luiza Morais Santos, et al.
Journal of Neurochemistry (2020) Vol. 156, Iss. 6, pp. 753-776
Open Access | Times Cited: 70
There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
Michael E. Makover, Michael D. Shapiro, Peter P. Tóth
American Journal of Preventive Cardiology (2022) Vol. 12, pp. 100371-100371
Open Access | Times Cited: 59
Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy
Michael Tran Duong, Ilya M. Nasrallah, David A. Wolk, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 57
Whole-genome sequencing of half-a-million UK Biobank participants
Shuwei Li, Keren Carss, Bjarni V. Halldórsson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Xiaojie Zhao, Siwei Zhang, Alan R. Sanders, et al.
Complex Psychiatry (2023) Vol. 9, Iss. 1-4, pp. 154-171
Open Access | Times Cited: 24
The Effect of APOE ε4 on Alzheimer's Disease Fluid Biomarkers: A Cross‐Sectional Study Based on the COAST
Bote Zhao, Peixi Zang, Meina Quan, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Genetic evidence for the liver-brain axis: lipid metabolism and neurodegenerative disease risk
Zeyu Wang, Zixiao Yin, Guangyong Sun, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework
Alexios‐Fotios A. Mentis, Efthimios Dardiotis, George P. Chrousos
Molecular Psychiatry (2020) Vol. 26, Iss. 4, pp. 1075-1097
Open Access | Times Cited: 57
Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis
Zhike Zhou, Yifan Liang, Xiaoqian Zhang, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 53
Cholesterol in Membranes Facilitates Aggregation of Amyloid β Protein at Physiologically Relevant Concentrations
Siddhartha Banerjee, Mohtadin Hashemi, Karen Zagorski, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 3, pp. 506-516
Open Access | Times Cited: 52
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
Cynthia Picard, Nathalie Nilsson, Anne Labonté, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 5, pp. 875-887
Open Access | Times Cited: 50
A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
J. Rudge
Journal of Alzheimer s Disease Reports (2022) Vol. 6, Iss. 1, pp. 129-161
Open Access | Times Cited: 37
Serum lipid traits and the risk of dementia: A cohort study of 254,575 women and 214,891 men in the UK Biobank
Jessica Gong, Katie Harris, Sanne A. E. Peters, et al.
EClinicalMedicine (2022) Vol. 54, pp. 101695-101695
Open Access | Times Cited: 37
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
Andrew S. Bell, Josephin Wagner, Daniel B. Rosoff, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105155-105155
Closed Access | Times Cited: 20
Mendelian randomization reveals apolipoprotein B shortens healthspan and possibly increases risk for Alzheimer’s disease
Leah Martin, Brian B. Boutwell, Carmen Messerlian, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
Francesco Gentile, Pietro Emiliano Doneddu, Nilo Riva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7471-7471
Open Access | Times Cited: 46
Paraoxonase Role in Human Neurodegenerative Diseases
Cadiele Oliana Reichert, Débora Levy, Sérgio Paulo Bydlowski
Antioxidants (2020) Vol. 10, Iss. 1, pp. 11-11
Open Access | Times Cited: 42
Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis
Lei Du, Jin Zhang, Fang Liu, et al.
Medical Image Analysis (2021) Vol. 70, pp. 102003-102003
Open Access | Times Cited: 36
LDL cholesterol is associated with higher AD neuropathology burden independent of APOE
Aliza P. Wingo, Selina Vattathil, Jiaqi Liu, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 9, pp. 930-938
Open Access | Times Cited: 25
Genetic Predisposition to Low-Density Lipoprotein Cholesterol May Increase Risks of Both Individual and Familial Alzheimer's Disease
Jiang-Shan Tan, Mengjin Hu, Yanmin Yang, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top